Overview Request Sample Pages Request Customization Download PDF
You are viewing: UK Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The UK Gastrointestinal Stent Market was valued at $32.02 Million in 2026 and projected to reach to $40.78 Million by 2031, representing a compound annual growth rate of 5.0%. The UK gastrointestinal stent market is positioned for consistent growth through 2031, supported by an aging population with rising gastrointestinal disease prevalence and strong NHS investment in endoscopic capabilities.

UK Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Gastrointestinal Stent Market Trends and Insights

  • The UK market benefits from advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong regulatory frameworks that support device innovation.
  • The UK's aging population and rising prevalence of gastrointestinal disorders continue to drive demand for stent-based interventions across both esophageal and biliary applications. The UK market is characterized by established clinical practices and reimbursement pathways that facilitate patient access to gastrointestinal stents.
  • The UK's National Health Service (NHS) and private healthcare sectors both contribute to market growth, with endoscopic stenting becoming increasingly routine in managing strictures, obstructions, and malignancies.
  • Between 2026 and 2031, the UK market will be shaped by technological advancements, including biodegradable and self-expanding stent designs, alongside growing clinical evidence supporting their efficacy..

Key Market Statistics

  • CAGR (2026-2031) 5.0% CAGR
  • Market Size, 2026 ~USD 32.02 Million
  • Forecast, 2031 ~USD 40.78 Million
  • Country UK

UK Gastrointestinal Stent Market Overview

Market Valuation Growth :

The UK gastrointestinal stent market is valued at $32.02 million in 2026 and is projected to reach $40.78 million by 2031, demonstrating steady expansion driven by healthcare investment and procedural demand.

Advanced Healthcare Infrastructure :

The UK's robust NHS framework and private healthcare sector support rapid adoption of minimally invasive stent technologies, with strong regulatory oversight from the MHRA ensuring device safety and efficacy standards.

Aging Population Dynamics :

The UK's aging demographic profile is driving increased prevalence of gastrointestinal disorders, including strictures, obstructions, and malignancies, creating sustained demand for stent interventions across NHS and private providers.

Minimally Invasive Procedure Adoption :

UK healthcare providers increasingly prefer endoscopic stent placement over surgical alternatives, reducing patient recovery times and hospital costs while improving clinical outcomes and patient satisfaction metrics.

UK Gastrointestinal Stent Market Dynamics

  • Healthcare providers across England, Scotland, Wales, and Northern Ireland are expanding minimally invasive procedure offerings, driving stent adoption in both benign and malignant indications.
  • Regulatory support from the MHRA and integration with digital health initiatives will further accelerate market expansion. Key growth drivers include increasing colorectal cancer screening programs, improved reimbursement pathways, and technological innovations in biodegradable and self-expanding stent designs.
  • The UK market will benefit from training programs for interventional endoscopists and growing awareness among gastroenterologists regarding stent efficacy.
  • Competition among device manufacturers will intensify, potentially improving product accessibility and driving price optimization across NHS procurement channels..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK gastrointestinal stent market is valued at $32.02 million in 2026 and will reach $40.78 million by 2031 at a 5.0% CAGR.
    • The UK's advanced healthcare infrastructure and NHS reimbursement support widespread adoption of minimally invasive stent procedures.
    • The UK market is driven by an aging population and increasing prevalence of esophageal and biliary disorders requiring endoscopic intervention.
    • Technological innovations in biodegradable and self-expanding stents are expected to accelerate UK market growth through 2031.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    UK Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    UK: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    AMBULATORY SURGICAL CENTERS2.52.62.72.933.23.43.55.5
    HOSPITALS & CLINICS20.321.222.123.124.225.326.527.84.7
    SPECIALTY ENDOSCOPY CENTERS/GI CLINICS6.56.87.27.688.48.99.45.6
    TOTAL29.330.63233.535.236.938.840.85

    Target Audience

    • Medical Device Manufacturers : Stent manufacturers need UK-specific market data to develop localized go-to-market strategies, understand NHS procurement requirements, and identify competitive positioning opportunities in this growing healthcare segment.
    • Healthcare Providers & NHS Trusts : Hospital procurement teams and gastroenterology departments require market intelligence to benchmark stent costs, evaluate supplier options, and justify capital investments in endoscopic equipment and consumables.
    • Private Healthcare Operators : Private hospital networks and independent treatment centers need market forecasts to plan service expansion, negotiate supplier contracts, and optimize stent inventory management for elective procedures.
    • Investment & Consulting Firms : Private equity investors, management consultants, and healthcare advisors require detailed UK market analysis to evaluate acquisition targets, assess growth potential, and develop investment theses in medical device sectors.
    • Regulatory & Policy Bodies : MHRA officials, NHS England planners, and health policy makers need market data to inform reimbursement decisions, establish clinical guidelines, and allocate healthcare resources effectively across gastrointestinal services.

    Key Companies in the UK Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Reasons to Buy this Report

    • NHS Procurement Intelligence : Gain detailed insights into NHS purchasing patterns, reimbursement frameworks, and tender opportunities for gastrointestinal stents across England, Scotland, Wales, and Northern Ireland to optimize market entry strategies.
    • Competitive Landscape Analysis : Understand the UK competitive positioning of major stent manufacturers, market share distribution, and emerging players to identify partnership opportunities and differentiation strategies specific to the British healthcare system.
    • Regulatory & Compliance Guidance : Access comprehensive information on MHRA approval pathways, CE marking requirements, and UK-specific regulatory changes post-Brexit to accelerate product launches and ensure compliance with evolving standards.
    • Clinical Practice Trends : Identify adoption patterns among UK gastroenterologists and interventional endoscopists, including preferred stent types, clinical indications, and training requirements to align product development with practitioner needs.
    • Growth Opportunity Mapping : Discover high-growth segments within the UK market, including aging population demographics, disease prevalence trends, and underserved regions to prioritize investment and resource allocation decisions.

    Frequently asked questions

    What is the current size of the UK gastrointestinal stent market?

    The UK gastrointestinal stent market is valued at $32.02 million in 2026 and is projected to grow to $40.78 million by 2031.

    What is the growth rate of the UK gastrointestinal stent market?

    The UK gastrointestinal stent market is expected to grow at a compound annual growth rate (CAGR) of 5.0% from 2026 to 2031.

    What factors are driving growth in the UK gastrointestinal stent market?

    Key drivers include the UK's aging population, rising prevalence of gastrointestinal disorders, advanced healthcare infrastructure, NHS reimbursement support, and technological innovations in stent design.

    Which types of gastrointestinal stents are most commonly used in the UK?

    The UK market utilizes both esophageal and biliary stents, with self-expanding metal stents (SEMS) and plastic stents being widely adopted for managing strictures, obstructions, and malignancies.

    How does the UK market compare to other European markets?

    The UK market benefits from established clinical practices, robust NHS infrastructure, and strong regulatory oversight, positioning it as a mature and stable segment within the broader European gastrointestinal stent market.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status